Single IRB Requirements: What Multi-Site Studies Need to Know
The landscape of multi-site clinical research changed dramatically with the implementation of single Institutional Review Board (sIRB) requirements. What was once a complex process involving multiple IRB reviews at each participating institution has been streamlined—but navigating these new requirements can still be challenging. Whether you're a clinical trial sponsor, principal investigator, or research administrator, understanding sIRB mandates is crucial for compliance and efficient study execution.
Understanding the Single IRB Mandate
In 2016, the revised Common Rule introduced a transformative requirement: for most federally funded multi-site studies in the United States, a single IRB of record must provide ethical oversight for all participating sites. This mandate, which became effective January 20, 2018, with full enforcement beginning in 2020, was designed to eliminate redundant reviews, reduce administrative burden, and accelerate research timelines.
The National Institutes of Health (NIH) took this a step further with its own sIRB policy, requiring NIH-funded multi-site studies to use a single IRB for ethical review, regardless of when the research was initiated.
Who Must Comply with sIRB Requirements?
Federal Research Mandates
The single IRB requirement applies to:
- NIH-funded research: All domestic multi-site studies involving non-exempt human subjects research, effective May 25, 2017
- Common Rule research: Cooperative research conducted or supported by federal departments and agencies that have adopted the revised Common Rule
- Clinical investigations: FDA-regulated studies involving an investigational drug, biological product, or device
Notably, the FDA has its own expectations around single IRB use. While not mandating sIRB review, the FDA encourages its use and has removed regulatory barriers that previously complicated single IRB reliance arrangements.
Exemptions and Exceptions
Some research may be exempt from sIRB requirements, including:
- Single-site studies
- Research that qualifies for exemption under the Common Rule
- Studies where multiple review is required by law (rare circumstances)
- International research sites (though the sIRB may still review domestic sites)
- Certain prison research or other specialized populations where local context is crucial
Key Components of sIRB Compliance
1. Selecting the IRB of Record
Choosing the appropriate single IRB is one of the most critical decisions in multi-site research. Options include:
Central or Commercial IRBs: Independent review boards specializing in multi-site research, offering expertise in complex protocols and established reliance infrastructure.
Lead Institution IRB: The IRB at the primary research institution, which may work well when that institution has significant multi-site review experience.
Consortium or Network IRB: Specialized IRBs established by research consortiums or networks for their collaborative studies.
Considerations when selecting an sIRB include: - Experience with similar research types - Turnaround times and responsiveness - Technology platforms for submission and communication - Geographic and therapeutic area expertise - Cost structure - Ability to handle the study's complexity and scope
2. Establishing Reliance Arrangements
For a single IRB model to work, all participating sites must formally agree to rely on the selected IRB. This is accomplished through reliance agreements or authorization agreements that:
- Clearly designate the reviewing IRB
- Define responsibilities of the reviewing IRB and relying institutions
- Establish lines of communication
- Address reporting requirements for adverse events and protocol deviations
- Clarify local context considerations
Smart SIRB: Many institutions now use the SMART IRB platform, a streamlined reliance process developed by the NIH that provides a master reliance agreement and straightforward authorization process for institutions across the country.
3. Addressing Local Context Requirements
While a single IRB provides centralized ethical review, local context cannot be ignored. Each participating site retains responsibility for:
- Ensuring local regulatory and institutional policy compliance
- Confirming adequate resources and facilities
- Verifying investigator qualifications and training
- Assessing community standards and local considerations
- Addressing institutional biosafety, conflict of interest, and other ancillary reviews
The sIRB should have a mechanism for sites to communicate local context concerns that might affect the ethical conduct of research at their location.
4. Streamlining the Review Process
Efficient sIRB review requires:
Centralized Submission: Typically, the lead investigator or sponsor submits the protocol, consent forms, and supporting documents to the single IRB.
Site-Specific Information: Individual sites provide local context documents, investigator CVs, training records, and facility information.
Coordinated Communication: A clear communication plan ensures that amendments, adverse events, and continuing review information flows appropriately between the sIRB, lead site, and participating locations.
Standardized Consent Forms: While local context may require some site-specific modifications, the goal is a primarily uniform consent document with minimal variations.
Timeline Considerations and Planning
Implementing a single IRB approach requires advance planning:
Pre-Submission Phase (4-8 weeks) - Identify and engage with potential participating sites - Select the IRB of record - Establish reliance agreements - Collect site-specific documents
Initial Review (2-6 weeks) - Submit to sIRB - Address any requests for modifications - Obtain sIRB approval
Site Activation (1-4 weeks per site) - Complete local ancillary reviews - Execute reliance agreements if not already in place - Finalize site-specific documents - Obtain local institutional authorization
Common Challenges and Solutions
Challenge 1: Institutional Resistance
Some institutions hesitate to cede IRB authority to an external board.
Solution: Emphasize regulatory requirements, efficiency gains, and retained local oversight through institutional authorization and local context review. Present data showing reduced administrative burden and faster activation times.
Challenge 2: Consent Form Variations
Local requirements may necessitate consent form modifications.
Solution: Work with the sIRB to develop a master consent template with clearly identified sections where local modifications are permissible. Most variations involve contact information and institutional-specific language rather than substantive ethical content.
Challenge 3: Adverse Event Reporting
Coordinating safety reporting across multiple sites through a single IRB requires clear protocols.
Solution: Establish explicit reporting pathways in the protocol and reliance agreement. Typically, sites report to the sponsor/lead investigator, who reports to the sIRB, which then communicates determinations back to all sites.
Challenge 4: Ancillary Review Delays
Local committees (biosafety, radioactive materials, etc.) can delay site activation even after sIRB approval.
Solution: Identify ancillary review requirements early and initiate parallel processes. Some ancillary reviews can begin before final sIRB approval using a draft protocol.
Best Practices for Single IRB Success
- Start Early: Begin sIRB planning during protocol development, not after the protocol is finalized.
- Communicate Proactively: Establish regular communication channels between the sIRB, sponsor, lead site, and participating institutions.
- Standardize Documentation: Use templates and standardized forms to reduce variability and streamline submissions.
- Leverage Technology: Utilize electronic systems that facilitate document sharing, version control, and audit trails across multiple sites.
- Train Study Teams: Ensure all site personnel understand the sIRB model, their responsibilities, and reporting requirements.
- Document Everything: Maintain clear records of reliance agreements, communications, and decisions throughout the study lifecycle.
- Plan for Amendments: Establish efficient processes for protocol amendments that will affect all sites simultaneously.
The Future of Single IRB Review
The single IRB requirement has fundamentally changed multi-site research oversight, and its impact continues to evolve. Emerging trends include:
- Increased adoption of sIRB for non-federally funded studies as sponsors recognize efficiency benefits
- Enhanced technology platforms facilitating seamless collaboration
- Greater standardization of reliance agreements and processes
- Expanded use of central IRBs with specialized expertise
- Evolution of hybrid models balancing centralized review with meaningful local input
Moving Forward with Confidence
Navigating single IRB requirements doesn't have to be overwhelming. With proper planning, clear communication, and experienced partners, the sIRB model delivers on its promise of more efficient, ethical review that accelerates important research while maintaining robust protections for human subjects.
Understanding compliance requirements, establishing strong reliance frameworks, and implementing best practices positions your multi-site study for success from protocol development through study closure.
Partner with Elemental IRB for Your Multi-Site Research
Elemental IRB specializes in single IRB review for multi-site clinical research. Our experienced team understands the complexities of coordinating ethical oversight across multiple institutions and regulatory frameworks. We offer streamlined reliance processes, responsive communication, and expertise across therapeutic areas to keep your research moving forward. Contact us today to learn how we can serve as your IRB of record and simplify your multi-site study management.